David Arkowitz, CFO: Seres Therapeutics MCRB Sell · Filed 24/02/16

Trade details

Type: Insider sale
Amount: $4,254.12
Shares · price: 3,939 sh · $1.08 a share
Held after: 182,442 sh
Stock: Seres Therapeutics MCRB
Person: David ArkowitzCFO
Trade date: 24/02/16
Filed: 24/02/16
Days to filing: 0 days

Sold 2.1% of holdings

Share of holding sold: 2.1%

Seres Therapeutics trades, last 26 weeks

What else happened in Seres Therapeutics around then

Filed or reported within 30 days of the trade day · 24/01/17~24/03/17

David Arkowitz's recent trades

David ArkowitzDirector
BuyiBio
Buy
iBio
IBIO
$50K
18,382 sh
$50K
Filed 25/01/13
Traded 25/01/10
David ArkowitzCFO
Sell10b5-1 planSeres Therapeutics
Sell10b5-1 plan
Seres Therapeutics
MCRB
$5,489
4,066 sh
$5,489
Filed 23/10/31
Traded 23/10/30